Patients first
Access, safety, and transparency drive our work.
We develop next-generation delivery platforms and clinically validated products to improve outcomes responsibly and at scale.
Access, safety, and transparency drive our work.
PQNS™ ensures superior bioavailability and tolerability.
Collaboration accelerates translation and impact.
The gut-friendly delivery platform improves bioavailability, ensures stability, and supports controlled release across diverse actives.
Three divisions, one mission: Pharmaceuticals, delivering evidence-based prescription therapies; Nutraceuticals, powered by PQNS for enhanced bioavailability and superior tolerance; and Cosmeceuticals, offering science-driven innovations for skin, hair, and overall beauty wellness.
Evidence-based Rx molecules and combinations designed for lipid control, glycemia, inflammation, pain and cardiovascular risk—integrated with monitoring and adherence.
PQNS-enabled formulations that achieve higher plasma exposure at lower doses—engineered for gut-friendly, sustained benefit.
Next-generation delivery engineered for higher bioavailability and consistent, gut-friendly performance.
Clinically demonstrated to achieve greater plasma exposure than widely used forms
Joint health solution—16 synergistic actives encapsulated in phospholipid nano-spheres for 85–90% uptake and >90% stability.
Highly purified EPA for triglyceride reduction and CV risk lowering in select high-risk patients as an adjunct to statin therapy.
Supports healthy aging with NAD+ boosting, antioxidant defense, and clinically backed cellular repair.
Updates from research, partnerships, and our communities.
From formulation to scale—CDMO engagements leveraging PQNS and our capsule/softgel platforms.
Explore open roles in R&D, manufacturing, clinical affairs, and more.
